Ulrike Jägle

Company: CureVac SE

Job title: Vice President Global Regulatory Affairs & Preclinical Safety

Seminars:

Panel Discussion – A European Industry & Regulatory Perspective on the Development & Approval of mRNA Medicines 5:30 pm

Uncovering how regulatory provisions can support mRNA medicines’ approval Reducing the regulatory approval timeline through platform technology approaches Moving towards a harmonized approach for mRNA medicines for the benefit of patientsRead more

day: Day 1 PM